DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers is a research paper published in eLife (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01 CA251138
National Heart, Lung, and Blood Institute
Grant: R01 HL128239
National Heart, Lung, and Blood Institute
Grant: R01 HL151651
The Leukemia & Lymphoma Society
Grant: 1344-18
NIGMS NIH HHS
Grant: T32 GM007266
NIGMS NIH HHS
Grant: T32 GM153182
National Institutes of Health
Grant: 5R01CA251138-03
Interrogating the minor spliceosome to understand and treat leukemia
National Institutes of Health
Grant: 2R01HL151651-06
Functional and molecular consequences of SF3B1 mutations in human hematopoietic stem cells
National Institutes of Health
Grant: 5R01HL128239-02
Genetic and molecular basis for SRSF2 mutations in myelodysplasia
FWCI
2.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals